Menu

Alcon Inc. ALC

Full chart Compare
Set alert

Price alert · ALC

All alert types
74.94 USD -1.61 (-2.10%)

At closeNov 6, 2026, 5:31 PM EST

74.94 0.00 0.00%

After hours · Nov 6, 5:31 PM ET

74.01 Day range 75.23
62.02 52-week range 87.18
YTD
-4.91%
1 year
+0.90%
Market cap
36.23B
Revenue (ttm)
10.86B
Profit margin
5.92%
EPS (ttm)
1.32
Shares out
483.40M
P/E ratio
56.77
Forward P/E
18.98
Dividend
0.36 (0.47%)
Ex-dividend date
May 5, 2026
YTD return
-4.91%
1-year return
+0.90%
Volume
3.17M
Avg volume
1.74M
Open
74.24
Previous close
76.55
Day's range
74.01 – 75.23
52-week range
62.02 – 87.18
Beta
0.72
Analysts
Buy
Price target
81.98 (+9.4%)
Earnings date
Nov 10, 2026

5D +2.63 (+3.64%)

72747678MonTueWedThuFri74.94

Key statistics

Enterprise value
40.85B
PEG ratio
1.33
Price / sales
3.34
Price / book
1.68
Dividend yield
0.47%
Payout ratio
26.56%
Revenue growth
8.70%
Free cash flow
1.27B
Total cash
1.46B
Total debt
5.30B
Return on equity
2.94%
Short % of float
0.00%
50-day average
67.77
200-day average
71.85

Financials — quick view

All financials
ALC Revenue — quarterly 2.82B
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ALC Net income — quarterly 0
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
ALC EPS — quarterly 0.00
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

ALC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 10, 2026Sep 30, 20260.89———
Aug 10, 2026Jun 30, 20260.770.84+0.07+9.09%
May 5, 2026Mar 31, 20260.800.85+0.05+6.25%
Feb 24, 2026Dec 31, 20250.790.78-0.01-1.27%
Nov 11, 2025Sep 30, 20250.770.79+0.02+2.60%
Aug 19, 2025Jun 30, 20250.710.76+0.05+7.04%

Upgrades / downgrades

ALC analyst upgrades and downgrades
DateFirmActionFromTo
Nov 2, 2026NeedhamreitBuyBuy
Oct 27, 2026KeybancmainOverweightOverweight
Oct 21, 2026NeedhamreitBuyBuy
Oct 12, 2026BTIGmainBuyBuy
Oct 7, 2026Barclaysinit—Equal-Weight
Sep 22, 2026JefferiesmainBuyBuy

About Alcon Inc.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. The company's cataract products include Unity CS, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; ADI cloud-based platform; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, Grieshaber, MIVS instruments; scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. In addition it also develops and commercializes therapies for chronic eye diseases, focusing on encapsulated cell therapy platforms for ocular conditions. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
Switzerland
Website
alcon.com

News

Your note

Sign in to keep a note on ALC — it syncs with the Stock Master app.

Institution ownership

ALC institution ownership
Holder% heldSharesValueReported
Vanguard Capital Management LLC2.95%14,749,5821.11BJun 29, 2026
NORGES BANK2.20%10,976,697822.81MJun 29, 2026
Invesco Ltd.2.08%10,380,332778.11MJun 29, 2026
Bank Of New York Mellon Corporation2.03%10,136,925759.86MSep 29, 2026
Aristotle Capital Management, LLC2.00%9,979,069748.03MJun 29, 2026
AKO Capital LLP1.94%9,683,004725.84MJun 29, 2026

Fund ownership

ALC fund ownership
Holder% heldSharesValueReported
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund1.44%7,175,218537.85MJul 30, 2026
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund0.95%4,758,876356.73MJun 29, 2026
iShares Trust-iShares Core MSCI EAFE ETF0.75%3,735,153279.99MSep 29, 2026
ALLSPRING FUNDS TRUST-Allspring Special Mid Cap Value Fund0.66%3,283,650246.14MAug 30, 2026
VANGUARD WINDSOR FUNDS-Vanguard Windsor II Fund0.58%2,918,000218.73MJul 30, 2026
MFS SERIES TRUST X-MFS International Intrinsic Equity Fund0.48%2,417,516181.22MAug 30, 2026